Table. Trends in Use and Expenditures Associated With Generic and Brand-name Atorvastatin Calcium Overall and by Insurance Status From 2012 to 2014a.
| Year | Millions | ||
|---|---|---|---|
| 2012 | 2013 | 2014 | |
| All Adults (MEPS Participants) | |||
| No. | 237 (n = 26 509) | 239 (n = 24 968) | 242 (n = 23 697) |
| Generic atorvastatin | |||
| Users, No. (%) | 8.6 (3.63) | 12.4 (5.20) | 14.3 (5.90) |
| Prescriptions, No. | 36.4 | 61.5 | 71.5 |
| Total expenditure, $ | 3480.0 | 4286.0 | 4980.0 |
| Total OOP expenditure, $ | 690.0 | 704.0 | 703.0 |
| Brand-name atorvastatin (Lipitor) | |||
| Users, No. (%) | 3.9 (1.65) | 0.8 (0.34) | 0.7 (0.29) |
| Prescriptions, No. | 13.9 | 3.3 | 2.5 |
| Total expenditure, $ | 3461.0 | 411.0 | 357.0 |
| Total OOP expenditure, $ | 352.0 | 77.0 | 19.0 |
| Excess expenditure, $ | 1891.0 | 133.0 | 113.0 |
| Adults With Public Insurance | |||
| No. | 66 | 68 | 74 |
| Generic atorvastatin | |||
| Users, No. (%) | 5.0 (7.50) | 7.5 (10.94) | 8.7 (11.71) |
| Prescriptions, No. | 21.5 | 37.1 | 44.4 |
| Total expenditure, $ | 2140.0 | 2660.0 | 3070.0 |
| Total OOP expenditure, $ | 369.0 | 337.0 | 364.0 |
| Brand-name atorvastatin (Lipitor) | |||
| Users, No. (%) | 2.2 (3.30) | 0.5 (0.08) | 0.3 (0.01) |
| Prescriptions, No. | 7.6 | 2.0 | 1.3 |
| Total expenditure, $ | 1850.0 | 282.0 | 276.0 |
| Total OOP expenditure, $ | 164.0 | 63.0 | 5.0 |
| Adults With Private Insurance | |||
| No. | 135 | 134 | 140 |
| Generic atorvastatin | |||
| Users, No. (%) | 3.5 (2.58) | 4.6 (3.42) | 5.4 (3.83) |
| Prescriptions, No. | 14.5 | 22.8 | 26.0 |
| Total expenditure, $ | 1300.0 | 1530.0 | 1870.0 |
| Total OOP expenditure, $ | 298.0 | 319.0 | 329.0 |
| Brand-name atorvastatin (Lipitor) | |||
| Users, No. (%) | 1.5 (1.15) | 0.2 (0.16) | 0.3 (0.25) |
| Prescriptions, No. | 5.7 | 1.0 | 1.2 |
| Total expenditure, $ | 1480.0 | 126.0 | 79.0 |
| Total OOP expenditure, $ | 141.0 | 12.0 | 13.0 |
| Uninsured Adults | |||
| No. | 36 | 37 | 28 |
| Generic atorvastatin | |||
| Users, No. (%) | 0.2 (0.43) | 0.3 (0.81) | 0.2 (0.86) |
| Prescriptions, No. | 0.5 | 1.7 | 1.1 |
| Total expenditure, $ | 41.0 | 96.0 | 41.0 |
| Total OOP expenditure, $ | 23.0 | 47.0 | 10.0 |
| Brand-name atorvastatin (Lipitor) | |||
| Users, No. (%) | 0.14 (0.38) | 0.07 (0.19) | 0.01 (0.01) |
| Prescriptions, No. | 0.6 | 0.3 | 0.04 |
| Total expenditure, $ | 131.0 | 3.8 | 1.8 |
| Total OOP expenditure, $ | 46.6 | 2.1 | 0.5 |
Abbreviations: GDP, gross domestic product; MEPS, Medical Expenditure Panel Survey; OOP, out-of-pocket.
a
All costs were adjusted to 2014 USD using GDP deflator.